Skip to content

Other product segments

Specialty
40.2%+74.8%
Financial
36%+25.0%
Casualty
23.8%+0.8%
Multiline
8.8%+22.2%
Property
3.8%+8.6%

Similar metrics at other companies

Axis Capital Holders logo
AXSInsurance — Year 4
14.8%
MetLife logo
METProtection Health — Short-duration Insurance Contracts, Historical Claims Duration, Year Four
0.5%+0.1pp
The Hartford Financial Services Group logo
HIGProperty Insurance — 4th Year
5%+1.1pp
Arch Capital Group logo
ACGLSpecialty — Year Four
6.7%+0.3pp
Arch Capital Group logo
ACGLThird party claims-made business — Year Four
12%+1.1pp
American International Group logo
AIGU.S. Personal Insurance — Year 4 (as a percent)
1.8%+1.3pp

Other financials

Income statement

See full
Revenue$189.7M-11.1%
Net income$35.8M+20.7%
EPS (diluted)$1.05+22.1%

Balance sheet

See full
Cash & equivalents$610.2M-5.1%
Total debt$4.7M-92.1%
Total equity$741.2M+11.2%
Total assets$2.3B+5.4%

Cash flow

See full
Operating cash flow$37.2M+259%

Valuation

See full
Market cap$533.32M+7.2%
Enterprise value-$72.18M-15.4%
P/E6.6×
P/S0.8×+0.1×

Profitability

See full
Net margin11.5%
FCF margin-46.7%

Returns & leverage

See full
Return on equity11.5%
Debt / equity-0.1×

Where this comes from

Reported directly by Greenlight Capital RE, Ltd. in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFour.

The official record: Greenlight Capital RE, Ltd.’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Greenlight Capital RE, Ltd.'s health — year 4.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Greenlight Capital RE, Ltd.'s health — year 4?
Greenlight Capital RE, Ltd. (GLRE) reported health — year 4 of 0% in Q4 2025.
What does health — year 4 mean?
Represents the cumulative claims development or loss experience for the health segment during the fourth year following the inception of the policy year. This metric provides insight into the tail-end risk and the finality of claims settlement for older health insurance contracts. Consistent performance here indicates robust actuarial modeling and risk management.